Dementia and Geriatric Cognitive Disorders

Research Article

Assessing the Prevalence of Undetected Possible Dementia in Faroese Nursing Homes

Petersen M.S.

Author affiliations

Department of Occupational Medicine and Public Health, The Faroese Hospital System, Tórshavn, Faeroe Islands
Faculty of Health Sciences, Centre of Health Science, University of the Faroe Islands, Tórshavn, Faeroe Islands

Keywords: Dementia diseaseCognitive screening testEpidemiologyNursing homes

Related Articles for ""
Dement Geriatr Cogn Disord 2019;48:30–38
https://doi.org/10.1159/000501607

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates

Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Research Article

Received: May 08, 2019
Accepted: June 19, 2019
Published online: July 18, 2019
Issue release date: December 2019

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 1

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Introduction: To assess the prevalence of possible dementia among nursing home residents in the Faroe Islands. Method: This cross-sectional study, undertaken in 2017, included all nursing homes in the Faroe Islands (n = 30), housing 591 residents. All residents were invited to participate, except those with an existing clinical diagnosis of dementia or living in dementia units (n = 207). A total of 232 residents participated, while 39 declined and 113 were unable to give consent, had died, or were not permanent residents at the time of examination. Cognitive screening was carried out using the Mini-Mental State Examination (MMSE) and the Informant Questionnaire on Cognitive Decline (IQCODE). Results: Possible dementia was found in 49% to 78% of the participants depending on the method used. According to both MMSE and IQCODE (AND rule), possible dementia was present in 105 participants (49%). According only to IQCODE, 119 participants (55%) scored above the cut-off (≥3.6), according to MMSE alone, 162 participants (72%) scored below the cut-off (≤24 on MMSE), while 175 participants (78%) screened positive according to either MMSE or IQCODE (OR rule). A rough estimate of the prevalence of possible dementia in the entire nursing home population (n = 591) including residents with known dementia and those with possible dementia from this study was between 61% and 73%. Conclusion:A high percentage (49–78%) of the participating nursing home residents without a pre-dementia diagnosis were assessed to have possible dementia based on screening with standardized tools, indicating a high degree of dementia underdiagnoses in Faroese nursing homes. This high prevalence of dementia is of significance for the clinical practice, running, and planning of nursing homes and pinpoints a need to act upon this, not only in the Faroes but also worldwide.

© 2019 S. Karger AG, Basel



Related Articles:

References

  1. Van Rensbergen G, Nawrot T. Medical conditions of nursing home admissions. BMC Geriatr. 2010 Jul;10(1):46.
    External Resources
  2. Hutsteiner P, Galler S, Mendoza M, Klünemann H. Prevalence of dementia in a rural nursing home population in Southern Germany. Eur J Psychiatry. 2013;27(3):174–84.
    External Resources
  3. Matthews FE, Dening T; UK Medical Research Council Cognitive Function and Ageing Study. Prevalence of dementia in institutional care. Lancet. 2002 Jul;360(9328):225–6.
    External Resources
  4. Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr. 2010 Nov;22(7):1025–39.
    External Resources
  5. Kowalska J, Rymaszewska J, Szczepanska-Gieracha J. Occurrence of cognitive impairment and depressive symptoms among the elderly in a nursing home facility. Adv Clin Exp Med. 2013 Jan-Feb;22(1):111–7.
  6. Helvik AS, Engedal K, Benth JS, Selbæk G. Prevalence and Severity of Dementia in Nursing Home Residents. Dement Geriatr Cogn Disord. 2015;40(3-4):166–77.
    External Resources
  7. Bergh S, Holmen J, Saltvedt I, Tambs K, Selbæk G. Dementia and neuropsychiatric symptoms in nursing-home patients in Nord-Trøndelag County. Tidsskr Nor Laegeforen. 2012 Sep;132(17):1956–9.
    External Resources
  8. Hoffmann F, Kaduszkiewicz H, Glaeske G, van den Bussche H, Koller D. Prevalence of dementia in nursing home and community-dwelling older adults in Germany. Aging Clin Exp Res. 2014 Oct;26(5):555–9.
    External Resources
  9. Røen I, Selbæk G, Kirkevold Ø, Engedal K, Testad I, Bergh S. Resourse Use and Disease Couse in dementia - Nursing Home (REDIC-NH), a longitudinal cohort study; design and patient characteristics at admission to Norwegian nursing homes. BMC Health Serv Res. 2017 May;17(1):365.
    External Resources
  10. Lithgow S, Jackson GA, Browne D. Estimating the prevalence of dementia: cognitive screening in Glasgow nursing homes. Int J Geriatr Psychiatry. 2012 Aug;27(8):785–91.
    External Resources
  11. Selbaek G, Kirkevold Ø, Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007 Sep;22(9):843–9.
    External Resources
  12. Cahill S, Diaz-Ponce AM, Coen RF, Walsh C. The underdetection of cognitive impairment in nursing homes in the Dublin area. The need for on-going cognitive assessment. Age Ageing. 2010 Jan;39(1):128–31.
    External Resources
  13. Auer SR, Höfler M, Linsmayer E, Beránková A, Prieschl D, Ratajczak P, et al. Cross-sectional study of prevalence of dementia, behavioural symptoms, mobility, pain and other health parameters in nursing homes in Austria and the Czech Republic: results from the DEMDATA project. BMC Geriatr. 2018 Aug;18(1):178.
    External Resources
  14. Wu YT, Beiser AS, Breteler MM, Fratiglioni L, Helmer C, Hendrie HC, et al. The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol. 2017 Jun;13(6):327–39.
    External Resources
  15. Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol. 2018 Nov;14(11):653–66.
    External Resources
  16. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N: Dementia prevention, intervention, and care. Lancet. 2017 Dec 16;390(10113):2673–734.
    External Resources
  17. Cadigan RO, Grabowski DC, Givens JL, Mitchell SL. The quality of advanced dementia care in the nursing home: the role of special care units. Med Care. 2012 Oct;50(10):856–62.
    External Resources
  18. Tible OP, Riese F, Savaskan E, von Gunten A. Best practice in the management of behavioural and psychological symptoms of dementia. Ther Adv Neurol Disorder. 2017 Aug;10(8):297–309.
    External Resources
  19. Wermuth L, Joensen P, Bünger N, Jeune B. High prevalence of Parkinson’s disease in the Faroe Islands. Neurology. 1997 Aug;49(2):426–32.
    External Resources
  20. Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grandjean P. Prevalence and incidence of Parkinson’s disease in The Faroe Islands. Acta Neurol Scand. 2008 Aug;118(2):126–31.
    External Resources
  21. Joensen P. High prevalence of primary focal dystonia in the Faroe Islands. Acta Neurol Scand. 2016 Jan;133(1):55–60.
    External Resources
  22. Joensen P. Multiple sclerosis incidence in the Faroe Islands 1986-2007. Acta Neurol Scand. 2010 May;121(5):348–53.
    External Resources
  23. Eliasen EH, Ferrer M, Gaini S, Louis ED, Petersen MS. Prevalence of Essential Tremor in the Faroe Islands: A Population-Based Study. Neuroepidemiology. 2019;52(3-4):227–36.
    External Resources
  24. Louis ED, Ferrer M, Eliasen EH, Gaini S, Petersen MS. Tremor in normal adults: A population-based study of 1158 adults in the Faroe Islands. J Neurol Sci. 2019 May;400:169–74.
    External Resources
  25. Joensen P. Incidence of amyotrophic lateral sclerosis in the Faroe Islands. Acta Neurol Scand. 2012 Jul;126(1):62–6.
    External Resources
  26. Johansen T, Olaffson A. The Faroe Islands: A Brief Introduction. Copenhagen: Faroese Government Office; 1999.
  27. Als TD, Jorgensen TH, Børglum AD, Petersen PA, Mors O, Wang AG. Highly discrepant proportions of female and male Scandinavian and British Isles ancestry within the isolated population of the Faroe Islands. Eur J Hum Genet. 2006 Apr;14(4):497–504.
    External Resources
  28. www.hagstova.fo
  29. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.
    External Resources
  30. Jorm AF. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med. 1994 Feb;24(1):145–53.
    External Resources
  31. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 2000 Jun;15(6):548–61.
    External Resources
  32. Marc LG, Raue PJ, Bruce ML. Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population. Am J Geriatr Psychiatry. 2008 Nov;16(11):914–21.
  33. Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016 Jan;(1):CD011145.
    External Resources
  34. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int Psychogeriatr. 2004 Sep;16(3):275–93.
    External Resources
  35. Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a general practice (primary care) setting. Cochrane Database Syst Rev. 2014 Jul;(7):CD010771.
    External Resources
  36. Harrison JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting. Cochrane Database Syst Rev. 2015 Mar;(3):CD010772.
    External Resources
  37. Rakusa M, Jensterle J, Mlakar J. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia. Dement Geriatr Cogn Disord. 2018;45(5-6):326–34.
    External Resources
  38. Knafelc R, Lo Giudice D, Harrigan S, Cook R, Flicker L, Mackinnon A, et al. The combination of cognitive testing and an informant questionnaire in screening for dementia. Age Ageing. 2003 Sep;32(5):541–7.
    External Resources
  39. Mackinnon A, Mulligan R. Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry. 1998 Nov;155(11):1529–35.
    External Resources
  40. Narasimhalu K, Lee J, Auchus AP, Chen CP. Improving detection of dementia in Asian patients with low education: combining the Mini-Mental State Examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Dement Geriatr Cogn Disord. 2008;25(1):17–22.
    External Resources
  41. Nielsen TR, Phung TK, Chaaya M, Mackinnon A, Waldemar G. Combining the Rowland Universal Dementia Assessment Scale and the Informant Questionnaire on Cognitive Decline in the Elderly to Improve Detection of Dementia in an Arabic-Speaking Population. Dement Geriatr Cogn Disord. 2016;41(1-2):46–54.
    External Resources
  42. Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open. 2017 Feb;7(2):e011146.
    External Resources
  43. Kirkevold Ø, Selbæk G. The Agreement between the MMSE and IQCODE Tests in a Community-Based Sample of Subjects Aged 70 Years or Older Receiving In-Home Nursing: An Explorative Study. Dement Geriatr Cogn Disord Extra. 2015 Feb;5(1):32–41.
    External Resources
  44. Phung TK, Chaaya M, Asmar K, Atweh S, Ghusn H, Khoury RM, et al. Performance of the 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE) in an Arabic-Speaking Older Population. Dement Geriatr Cogn Disord. 2015;40(5-6):276–89.
    External Resources

Article / Publication Details

First-Page Preview
Abstract of Research Article

Received: May 08, 2019
Accepted: June 19, 2019
Published online: July 18, 2019
Issue release date: December 2019

Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 1

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

2019, Vol.48, No. 1-2

December 2019

Article

Recommend This
TOP